CYTRX CORP
10-Q, EX-27.1, 2000-10-31
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: CYTRX CORP, 10-Q, 2000-10-31
Next: CYTRX CORP, 10-Q, EX-27.2, 2000-10-31



<TABLE> <S> <C>

<PAGE>

<ARTICLE> 5

<S>                             <C>                     <C>
<PERIOD-TYPE>                   3-MOS                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000             DEC-31-2000
<PERIOD-START>                             JUL-01-2000             JAN-01-2000
<PERIOD-END>                               SEP-30-2000             SEP-30-2000
<CASH>                                       2,172,799                       0
<SECURITIES>                                         0                       0
<RECEIVABLES>                                  169,102                       0
<ALLOWANCES>                                         0                       0
<INVENTORY>                                          0                       0
<CURRENT-ASSETS>                             2,396,112                       0
<PP&E>                                       2,121,484                       0
<DEPRECIATION>                               (680,763)                       0
<TOTAL-ASSETS>                               5,506,824                       0
<CURRENT-LIABILITIES>                        1,235,374                       0
<BONDS>                                              0                       0
                                0                       0
                                          0                       0
<COMMON>                                        10,696                       0
<OTHER-SE>                                   4,260,754                       0
<TOTAL-LIABILITY-AND-EQUITY>                 5,506,824                       0
<SALES>                                        168,086                 353,370
<TOTAL-REVENUES>                               403,942               1,037,412
<CGS>                                           82,035                 178,736
<TOTAL-COSTS>                                   82,035                 178,736
<OTHER-EXPENSES>                               928,099               3,166,888
<LOSS-PROVISION>                                     0                       0
<INTEREST-EXPENSE>                                   0                       0
<INCOME-PRETAX>                              (606,192)             (2,308,212)
<INCOME-TAX>                                         0                       0
<INCOME-CONTINUING>                          (606,192)             (2,308,212)
<DISCONTINUED>                                       0                 799,328
<EXTRAORDINARY>                                      0                       0
<CHANGES>                                            0                       0
<NET-INCOME>                                 (606,192)             (1,508,884)
<EPS-BASIC>                                      (.06)                   (.16)
<EPS-DILUTED>                                    (.06)                   (.16)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission